Cite

HARVARD Citation

    Nayar, R. et al. (n.d.). 156 Discovery of TSC-100: A natural HA-1-specific TCR to treat leukemia following hematopoietic stem cell transplant therapy. Journal for immunotherapy of cancer. p. A170. [Online]. 
  
Back to record